What is the Market's View on Exagen Inc (XGN) Stock's Price and Volume Trends Friday?

Friday, December 09, 2022 03:38 PM | InvestorsObserver Analysts

Mentioned in this article

Exagen Inc (XGN) stock is higher by 8.43% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Exagen Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on XGN!
See Full XGN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With XGN Stock Today?

Exagen Inc (XGN) stock is higher by 5.06% while the S&P 500 is down -0.34% as of 3:37 PM on Friday, Dec 9. XGN is up $0.13 from the previous closing price of $2.57 on volume of 153,260 shares. Over the past year the S&P 500 is lower by -15.98% while XGN is down -74.70%. XGN lost -$2.35 per share in the over the last 12 months. To screen for more stocks like Exagen Inc click here.

More About Exagen Inc

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Click Here to get the full Stock Report for Exagen Inc stock.

Share this article:

Related Articles